Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study
-
By
-
Alisa Salmivalli
-
Otto Ettala
-
Peter J. Boström
-
Ville Kytö
-
April 16, 2022
-
Clinical Scorecard: Postoperative Mortality Rates in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Nationwide Cohort Analysis
At a Glance
| Category | Detail |
|---|
| Condition | Benign Prostatic Hyperplasia (BPH) |
| Key Mechanisms | Lower urinary tract symptoms due to prostate enlargement; surgical removal or ablation to relieve obstruction |
| Target Population | Men undergoing elective surgery for BPH, primarily older adults with varying comorbidity burdens |
| Care Setting | Elective surgical procedures in hospital operating centers across Finland |
Key Highlights
- Surgical treatments for BPH include TURP, laser vaporization, and open prostatectomy, with TURP being the most common.
- Postoperative 90-day mortality rates vary by procedure: TURP (1.16%), laser vaporization (0.59%), open prostatectomy (0.35–0.51%).
- Older age and comorbidities increase risk of serious complications and mortality after BPH surgery.
Guideline-Based Recommendations
Diagnosis
- Exclude patients with non-prostate malignancies or urinary system neoplasms before surgery.
- Assess comorbidity burden using Charlson comorbidity index (CCI).
- Consider atrial fibrillation as a surrogate marker for oral anticoagulation use.
Management
- Select surgical technique based on prostate size, patient age, and comorbidities.
- TURP remains therapy of choice; laser vaporization is a less invasive alternative.
- Open prostatectomy reserved for large prostates but becoming less common.
Monitoring & Follow-up
- Monitor postoperative mortality within 90 days and up to 1 year after surgery.
- Track causes of death categorized by underlying and immediate causes.
- Consider surgical center volume as a factor influencing outcomes.
Risks
- Increased postoperative mortality associated with older age and higher comorbidity burden.
- Potential serious complications linked to endourologic surgery in elderly and comorbid patients.
- No definitive data showing significant mortality differences between surgical techniques.
Patient & Prescribing Data
Elective BPH surgery patients without emergency operations or institutional care admissions.
Majority had low comorbidity (70% with CCI=0); 7% had atrial fibrillation; TURP was predominant procedure.
Clinical Best Practices
- Carefully evaluate risks and benefits of surgical options in elderly and comorbid patients.
- Use comprehensive registries and administrative data to monitor outcomes and mortality.
- Prefer high-volume centers for BPH surgeries to potentially improve outcomes.
References
